Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-24 @ 11:17 PM
NCT ID:
NCT02472756
Brief Title:
A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma
Official Title:
Relapsed/Refractory Follicular Lymphoma - Rituximab Therapy in Combination With Chemotherapy
Acronym:
REFLECT 2
Study:
NCT02472756
Protocol Section:
NCT02472756